Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives
February 19, 2020
Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug pricing initiatives circulating in Washington.
To listen to the 15-minute podcast, click here.